Yurpeak 5mg KwikPen (Tirzepatide)

Yurpeak 5mg KwikPen contains Tirzepatide 5mg, an injectable prescription medicine marketed by Cipla Limited in India under an agreement with Eli Lilly. It belongs to a class of medicines known as dual GIP and GLP-1 receptor agonists. Yurpeak is used as part of a comprehensive treatment approach for adults with type 2 diabetes and for chronic weight management in eligible adults, alongside appropriate dietary and lifestyle measures.

Yurpeak 5mg KwikPen is supplied in a prefilled, multi-dose injection pen designed for subcutaneous administration. Each KwikPen contains four fixed doses for weekly administration. Treatment must be initiated and monitored by a qualified healthcare professional.

Yurpeak 5mg KwikPen – Composition and Specifications

- Brand Name: Yurpeak

- Generic Name: Tirzepatide

- Strength: 5mg

- Dosage Form: Solution for Injection

- Packaging: Multi-dose prefilled KwikPen

- Route of Administration: Subcutaneous injection

- Administration Frequency: Once weekly, as prescribed

- Manufacturer/Supply Arrangement: Eli Lilly manufactures and supplies Yurpeak to Cipla for distribution in India.

Uses and Therapeutic Information

Tirzepatide acts on glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. These hormonal pathways are involved in regulating blood glucose levels, insulin secretion and appetite.

Yurpeak may be prescribed for:

1. Type 2 Diabetes Management

Tirzepatide helps improve blood glucose control in adults with type 2 diabetes when used alongside dietary modifications and physical activity.

2. Chronic Weight Management

In eligible adults with obesity or overweight accompanied by weight-related medical conditions, tirzepatide may support long-term weight management as part of a medically supervised treatment programme.

Dosage and Administration

Yurpeak 5mg KwikPen should be administered according to the treating physician's prescription. The appropriate dose and treatment progression depend on individual patient requirements, medical history and treatment response.

Patients should not independently increase, decrease or discontinue their prescribed dosage. Healthcare professionals should provide appropriate instructions regarding pen operation, injection technique and disposal.

Side Effects and Safety Information

Commonly reported adverse reactions associated with tirzepatide include nausea, vomiting, diarrhoea, constipation and abdominal discomfort.

Important precautions include the potential risk of pancreatitis, gallbladder problems, dehydration-related kidney injury and hypoglycaemia, particularly when used with certain other diabetes medicines. Patients should inform their doctor about existing medical conditions and other medications before starting treatment.

Yurpeak is a prescription medicine and should only be used under qualified medical supervision.

Storage and Handling

Maintain the manufacturer's recommended storage conditions and cold-chain requirements. Protect the product from freezing and excessive heat. Follow the approved product packaging and prescribing information for handling and storage instructions.

Why Choose Cordium Pharmaceuticals?

Cordium Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical supplier, distributor and exporter catering to international pharmaceutical sourcing requirements.

We facilitate pharmaceutical product enquiries for importers, distributors, healthcare procurement organisations and other eligible business buyers. Our focus includes responsible product sourcing, transparent communication and export documentation support, subject to applicable regulatory requirements.

For Yurpeak 5mg KwikPen availability, commercial quotations, bulk sourcing requirements and international pharmaceutical export enquiries, contact our team.

Frequently Asked Questions

1. What is the active ingredient in Yurpeak 5mg KwikPen?

It contains Tirzepatide 5mg.

2. How frequently is Yurpeak administered?

It is generally administered once weekly according to a doctor's prescription.

3. Is Yurpeak 5mg a prescription medicine?

Yes. It requires a valid prescription and medical supervision.

4. Where can I enquire about Yurpeak 5mg KwikPen supply?

Contact Cordium Pharmaceuticals for product availability, sourcing and eligible pharmaceutical export enquiries.